Comparison of lignocaine spray versus normal saline spray for pain relief during intravenous Cannulation in adults

Comparison of lignocaine spray ten percent versus normal saline spray for pain relief during intravenous Cannulation in adults - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088231

Enrollment

Registered

2025-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Lignocaine: Before normal skin disinfection lignocaine spray wil be applied 5 times from a distance of 5 cm, it would deliver a total of 50 mg, skin disinfectant will be performed after

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA physical status 1 and 2. 2.Aged between 18-65 years of old of either sex. 3.Patients undergoing any operation. 4.Patients who will give consent.

Exclusion criteria

Exclusion criteria: 1.Allergy or sensitivity to lignocaine. 2.Pregnant. 3.Breastfeeding. 4.Concomitant use of an analgesic within the previous 24 hour. 5.Inability to understand and use of Visual Analogue Scale (VAS). 6.Patients having peripheral neuropathy or skin abrasions or diseases (eczema, Psoriasis, infection). 7.Difficulties in verbal communication.

Design outcomes

Primary

Measure	Time frame
Comparison of VAS score assessed immediately after IV CannulationTimepoint: Immediately after IV Cannulation	—

Secondary

Measure	Time frame
Rash, erythema or Pruritus occurred after Cannulation if any.Timepoint: After IV Cannulation	—

Countries

India

Contacts

Public ContactDr Sangita Mandal

Institute of post graduate medical education and research, Kolkata

sangitamandal1@gmail.com7980735443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026